• CAN-2409 Mechanism of Action
  • CAN-3110 Mechanism of Action
  • Careers
  • Investigator Login
  • About
  • Platforms
  • Pipeline
  • Patients
  • Investors
  • Media
  • News
  • Contact
  • Menu Menu

Candel Therapeutics Announces Pricing of Initial Public Offering

Press Release
/wp-content/uploads/candel_logo.svg 0 0 cchan@candeltx.com /wp-content/uploads/candel_logo.svg cchan@candeltx.com2021-07-26 18:24:192025-06-16 07:43:14Candel Therapeutics Announces Pricing of Initial Public Offering

Candel Therapeutics Appoints Diem Nguyen, Ph.D., M.B.A., to its Board of Directors

Press Release
/wp-content/uploads/candel_logo.svg 0 0 cchan@candeltx.com /wp-content/uploads/candel_logo.svg cchan@candeltx.com2021-07-15 05:00:192025-06-16 07:45:10Candel Therapeutics Appoints Diem Nguyen, Ph.D., M.B.A., to its Board of Directors

Candel Therapeutics to Present at Upcoming Jefferies Virtual Healthcare Conference

Press Release
/wp-content/uploads/candel_logo.svg 0 0 cchan@candeltx.com /wp-content/uploads/candel_logo.svg cchan@candeltx.com2021-05-27 05:00:092025-06-16 07:53:50Candel Therapeutics to Present at Upcoming Jefferies Virtual Healthcare Conference

Candel Therapeutics Names Carrie S. Cox as Chairman of its Board of Directors

Press Release
/wp-content/uploads/candel_logo.svg 0 0 cchan@candeltx.com /wp-content/uploads/candel_logo.svg cchan@candeltx.com2021-05-11 05:00:172025-06-16 07:51:43Candel Therapeutics Names Carrie S. Cox as Chairman of its Board of Directors

Candel Therapeutics’ CAN-3110 Clinical Data Selected for Oral Presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

Press Release
/wp-content/uploads/candel_logo.svg 0 0 cchan@candeltx.com /wp-content/uploads/candel_logo.svg cchan@candeltx.com2021-04-29 05:00:212025-06-16 07:48:55Candel Therapeutics’ CAN-3110 Clinical Data Selected for Oral Presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

Candel Therapeutics Completes Enrollment in Phase 1 Clinical Trial of CAN-2409 in Combination with Opdivo® (nivolumab) for the Treatment of High-Grade Gliomas

Press Release
/wp-content/uploads/candel_logo.svg 0 0 cchan@candeltx.com /wp-content/uploads/candel_logo.svg cchan@candeltx.com2021-04-22 05:14:122025-06-16 07:50:44Candel Therapeutics Completes Enrollment in Phase 1 Clinical Trial of CAN-2409 in Combination with Opdivo® (nivolumab) for the Treatment of High-Grade Gliomas

Candel Therapeutics Appoints Chris Matheny, PharmD, Ph.D., as Vice President, Development Leader

Press Release
/wp-content/uploads/candel_logo.svg 0 0 cchan@candeltx.com /wp-content/uploads/candel_logo.svg cchan@candeltx.com2021-04-09 05:02:342025-06-16 07:47:20Candel Therapeutics Appoints Chris Matheny, PharmD, Ph.D., as Vice President, Development Leader

Candel Therapeutics Appoints Pharma Veteran and Immunologist Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer; Expands Leadership Team With Chief Financial Officer, Chief Business Officer and Chief Regulatory Officer Appointments

Press Release
/wp-content/uploads/candel_logo.svg 0 0 Vince Rose /wp-content/uploads/candel_logo.svg Vince Rose2020-12-08 08:00:532025-06-16 07:46:24Candel Therapeutics Appoints Pharma Veteran and Immunologist Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer; Expands Leadership Team With Chief Financial Officer, Chief Business Officer and Chief Regulatory Officer Appointments

Candel Therapeutics Announces Presentation of Clinical Data for GMCI in NSCLC at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

Press Release
/wp-content/uploads/candel_logo.svg 0 0 Vince Rose /wp-content/uploads/candel_logo.svg Vince Rose2020-05-30 08:00:392025-06-16 07:41:15Candel Therapeutics Announces Presentation of Clinical Data for GMCI in NSCLC at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

Candel Therapeutics Announces Presentation at the 2020 American Society of Gene and Cell Therapy (ASGCT) 23rd Annual Meeting

Press Release
/wp-content/uploads/candel_logo.svg 0 0 Vince Rose /wp-content/uploads/candel_logo.svg Vince Rose2020-05-18 08:00:012025-06-16 07:39:22Candel Therapeutics Announces Presentation at the 2020 American Society of Gene and Cell Therapy (ASGCT) 23rd Annual Meeting
Page 1 of 212
© 2025 by Candel Therapeutics
Scroll to top Scroll to top Scroll to top